QVT Financial LP

13F Holdings History for Tourmaline Bio, Inc. - Common Stock, par value $0.0001 per share (TRML)

Symbol: TRML on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 2.15M shares
Security Ownership: 8.39%

Shares, Excluding Options vs Price

Value, Excluding Options

QVT Financial LP ownership in Tourmaline Bio, Inc. Common Stock, par value $0.0001 per share (TRML)

2025-08-14 - QVT Financial LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.15M shares of Tourmaline Bio, Inc. Common Stock, par value $0.0001 per share (TRML). This represents 8.39% percent ownership of the company. In their previous filing dated 2025-05-15, QVT Financial LP had reported owning 1.47M shares, indicating an increase of 46.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
QVT Financial LP	8.39%	+44.2%	$49.7M	2.15M	+681,284	+46.2%	$23.06	13G/A	6/30/2025	14 Aug 2025 16:00:51
QVT Financial LP	5.74%		$18.6M	1.47M			$12.62	13G	3/31/2025	15 May 2025 16:22:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	4.81%	+1.52%	$34.5M	2.15M	+681,284	+46.2%	$15.99	Q2 2025
3/31/2025	2.14%	+1.1%	$22.4M	1.47M	+762,094	+100%	$15.21	Q1 2025
12/31/2024	1.29%		$14.4M	711K			$20.28	Q4 2024
9/30/2024	1.57%		$18.3M	711K			$25.71	Q3 2024
6/30/2024	0.86%	-0.28%	$9.15M	711K	-237,091	-25%	$12.86	Q2 2024
3/31/2024	2.05%	0%	$22M	948K	-1	0%	$23.19	Q1 2024
12/31/2023	1.5%	+1.4%	$24.8M	948K	+948,367	NEW	$26.18	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.